Ali Alhimiri, MD is the Principal Founder of MODUS and is a Physical Medicine & Rehabilitation Physician who has been providing cost-effective, high quality care to thousands of patients in Southeast Michigan since 2002. His experience in treating patients with pain led directly to the development of MODUS, a digital health platform that improves patient access to evidence-based care, enables employers to implement value-based contracting technology, and rewards physicians for positive outcomes.
eSimplify is a predictive practice analytics platform for primary care physicians. eSimplify helps primary care physicians maximize revenue, identify gaps in care and, most importantly, improve the quality of care for their patients. eSimplify's analysis has shown that primary care practices are leaving billons of dollars in recoverable revenue on the table. As healthcare providers shift to a value-based payment model, eSimplify’s affordable analytics helps small to mid-sized practices successfully make that transition. Founded in 2018, eSimplify is currently focused on primary care physician practice but will be expanding to other specialties in the near future.
Pradeep Kalmat is the founder and CEO of eSimplify. Pradeep worked at Aon Hewitt for over 18 years and was responsible for delivering high quality services in a highly challenging environment across various areas of human resource management. The demanding accuracy requirement of 99% or higher in that field prepared him to rely on data and metrics that provided meaningful insights to identify inefficiencies and improve processes. Pradeep relied on this knowledge and expertise to assess the market and then design, develop, and deploy eSimplify with the specific goal of creating value for primary care physician and other providers.
RIZZARR is a tech-enabled content marketplace for brands to work with Millennial and Gen Z content creators worldwide. RIZZARR acts as an intermediary marketing platform for brands to find, connect, and collaborate with over 5,300 content creators from around the world. RIZZARR helps Millennial and Gen Z nano-influencers and micro-influencers to authentically produce high-quality videos, selfie videos, podcasts, social posts, articles, and photos for brands to use across their apps, social media, and other digital media properties.
Ashley M. Williams is the founder and CEO of RIZZARR. She also founded Millennials Change, an event series created to inspire Millennials to make a positive impact on the world. Before starting her journey into entrepreneurship, Ashley was an award-winning journalist working for NBC News, WBAL Radio, and USA TODAY. She graduated with honors from the University of Southern California, earning a B.A. in broadcast and digital journalism as well as minors in international relations and Spanish. As a collegiate debater, she received a scholarship and placement on the USC Trojan Debate Squad. In her spare time, Ashley is a board member for various mission-driven entities including Techbridge Girls and the National Association for Media Literacy Education.
AuraLab LLC is focused on developing innovative technologies to promote Deep Slow Breathing, a clinically validated practice that reduces anxiety and promotes wellness. Stress is on the rise globally, and the U.S. is currently in the lead with some of the highest rates in the world. Breathscape™ is the first iOS application that accurately analyzes the breath in real-time and provides continuous biofeedback, effectively training individuals to relax the nervous system through Deep Slow Breathing. After extensive Beta testing with more than 500 users, Breathscape was released on the Apple store on 4/4/2020.
AuraLab was founded in 2018. Co-Founder and CEO Robert Alexander was formerly a NASA fellow, Dr. Alexander worked with scientists at Goddard Space Flight Center to transform our understanding of the sun and solar wind through auditory data analysis. Before launching AuraLab he worked as a Chief Innovation Officer at U of M, and for a year and a half he sat as the Psychology department chair for the MSc/MET program at the renowned HK PolyU School of Design where he lectured on Sound Design and Design Psychology.
Connect To My Attorney
Connect To My Attorney (CTMA) has developed a disruptive solution that allows clients to search for, find and spontaneously connect with an attorney in a convenient, efficient and economical manner from their smart phones.
CTMA is the only video App that provides an attorney/client online privileged communication from anywhere and, can be conducted in English, Spanish or Arabic. CTMA is a comprehensive WebRTC-based peer-to-peer, encrypted, connection between the client and attorney. Only the attorney and client can use the channel - the audio and video cannot be accessed by any other party, including the initiating server. CTMA’s application incorporates voice recognition, geo-location, encrypted document exchange, time monitoring, texting, and, can be utilized with up to 5 participants.
The Total Addressable Market for CTMA is $5.4 Billion, based on subscription fees from attorneys in private practice in the US. Founder and CEO Peter J. Staver is a licensed attorney with over 30 years of experience as a managing partner for Staver & Anderson, P.C.
Kevin Hagedorn, Ph. D. is a materials scientist with nine issued patents and seven peer reviewed publications. His expertise is using physics simulations to design materials, devices, and products. He's applied this expertise to a diverse range of problems including the design of solar cells, laser cutting and welding equipment, and now to the transport and storage of RNA for diagnostic and therapeutic applications. He's won two small business grants from the National Science Foundation to develop the product.
Life Magnetics manufactures products for processing, storage, and transport of RNA. RNA testing accounts for 40% molecular testing in medical diagnostic labs and research labs, but it's a difficult molecule to work with. Unlike DNA, which is stable for hundreds of years, RNA is stable for only 28 minutes. RNA shipping and transport is set to become a major obstacle for biopharma as RNA drugs and RNA diagnostics are predicted to be two of the biggest growth sectors. The company has the best solution to date for this 40-year-old problem with NASA proposing to use the product on a mission to the International Space Station in 2020.
eScapes Network LLC
eScapes Network LLC is a Michigan company that has developed, patented, and produces Therapeutic Relaxation Television whose purpose is to provide anti-stress and anti-anxiety entertainment to both public and private networks. Our first private network product, Relaxation Dental TV has been endorsed by five state dental associations and is now enjoyed by nearly 600 dentists, their staff, and thousands of patients. These Private Television Networks are monetized by Verizon Media’s programmatic advertising platform.
After graduating from college in 1970 Robert enlisted in the US Navy and served in the Vietnam War. Spending nearly four years on an ammunition ship introduced him to the world of power machines and electro hydraulics, so after service he entered the power plant construction industry where his career in that industry culminated with the supervision of the installation of all machine components of the Enrico Fermi Atomic Power Plant. During those years, he and his brother Eli developed and patented several hydraulic pump and turbine devices for the desalination industry that lead to the formation of Pump Engineering Inc. in 1986. Pump Engineering sold in late 2009 for $27 Million, an ROI of 3400% for investors. Robert was now “free” to pursue an opportunity he had identified, which was combining radio like programing with television, now known as Therapeutic Relaxation Television.
EagleView Imaging, Inc. (“EagleView”), is a Michigan company developing state of the art imaging technologies for doctors, surgeons and other medical specialists. Our first product, a 3D augmented reality (AR), ergonomic desktop surgical planning system will make complex neurosurgery intuitive and precise at an affordable cost.
In more than 40 years of executive leadership and technology startups, Francis has played critical roles in seven startups, four large-scale turnarounds and three large financial exits and post-merger restructurings in the IT and MedTech sectors. Throughout, he gained a reputation as a skilled strategist, negotiator and international business developer, driving partnerships and large transactions. Francis is currently the Co-founder and CEO of EagleView Imaging, Inc., a medical imaging early stage company. He is also a board member at New Enterprise Forum in Ann Arbor
Giggso is an integrated big data platform to manage collaboration tools and business apps, with cross-platform search, engagement incentives, and actionable insights. Giggso is available on saas or customized for the enterprise with their business and security needs.
Ravi Venugopal, founder & CEO of Giggso, is a serial entrepreneur, innovator and data evangelist. He specializes in Big data, AI/ML and Data engineering. Ravi has vertical experience for more than two decades in Finance, Automotive & Retail business areas.
Ravi has successfully completed two exits. Giggso is his third venture.
CEO/Chair of the Board: David F. Keren, MD. As a senior clinical pathologist, Dr. Keren served 22 years at the helm of Warde Medical Laboratory. In addition, Dr. Keren has many years of leadership experience at the University of Michigan including Director of the Clinical Laboratories and Chair of the Molecular Test Committee. He also has held leadership positions on several non-profit professional boards including serving as President of the American Board of Pathology. Dr. Keren provides experienced and capable leadership to InheRET.
InheRET, Inc. is a startup SaaS company from the University of Michigan developing decision support software to identify patients at increased risk for hereditary diseases and increasing patient access to preventative care. The InheRET online family history collection and interpretation tool addresses the time, accuracy and interpretation of family history barriers faced by clinicians and streamlines the process into easy-to-understand reports with clear next steps for healthcare providers and patients alike. InheRET currently focuses on hereditary cancers, but aims to expand to other hereditary diseases in the near future.